2017—2018年某医院ICU病房使用麻醉药品的合理性评估

doi:10.3969/j.issn.1006-5253.2020.02.003

Abstract
Figure/Table
References (0)
Related Citation (0)

Download: PDF (883 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the rational evaluation of the use of narcotic drugs in ICU of a hospital, and to provide reference for the optimization of the management and rational use of narcotic drugs. Methods Data of the use of narcotic drugs in ICU from 2017 to 2018 were collected. The rationality of the use of narcotic drugs was evaluated by DDDs, DDC and DUI. Results There were records of using eight kinds of narcotic drugs. The top three DDDs were fentanyl injection (3 500.0), remifentanil injection (900.0) and fentanyl transdermal patch (480.0). The top three DDC were codeine tablets (900.9 yuan), propofol (662.0 yuan), and buguizine injection (604.1 yuan). There were 3 kinds of DUI>1: fentanyl injection (6.29), remifentanil injection（1.18) and fentanyl transdermal patch (4.84). Among the diseases in ICU, the dosage of fentanyl injection was still the largest for tumor, accidental injury and sepsis. Conclusion The use of some anesthetics in ICU of a hospital may be unreasonable, and the management and rational use of anesthetics need to be further optimized.

Key words： narcotic drug ICU rationality evaluation

Received: 17 July 2019

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Ye Yingying
	Zheng Li′na
	Xie Xiaodan

Cite this article:

Ye Yingying,Zheng Li′na,Xie Xiaodan. Rationality evaluation of using narcotic drugs in ICU of a hospital from 2017 to 2018[J]. journal1, 2020, 27(2): 106-108.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2020.02.003 OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2020/V27/I2/106

［1］ZHU Y, WANG Y, DU B, et al. Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients A systematic review and metaanalysis［J］. Crit Care, 2017,21(1):206.

［2］吕小群,张军.我院2012—2014年住院患者麻醉药品使用分析［J］.中国药房,2016,27(5):590-593.

［3］RAAD M, JAIN A, NEUMAN B J, et al. Association of patientreported narcotic use with shortand longterm outcomes after adult spinal deformity surgery: multicenter study of 425 patients with 2year followup［J］. Spine (Phila Pa 1976), 2018,43(19):1340-1346.

［4］李爱香,张婕.我院ICU麻醉药品使用情况分析［J］.海峡药学,2017,29(5):225-227.

［5］刘全义,杨亮蕊,郑杨.我院2012—2017年住院患者麻醉药品使用情况分析［J］.中国当代医药,2019,26(4):195-199.

［6］MERCHAN C, ALTSHULER D, PAPADOPOULOS J. Methylnaltrexone versus naloxone for opioidinduced constipation in the medical intensive care unit［J］. Ann Pharmacother, 2017,51(3):203-208.

［7］张薇.以限定日剂量值为基础进行药物利用研究的影响因素分析［J］.中国全科医学,2010,13(25):2892-2894.

［8］宫曙光.比对6个版次的《新编药物学》看我国临床降压药物发展［J］.中国药房,2007,31(18):2467-2468.

［9］徐彤彤,许筱.我院住院病人麻醉药品使用情况分析［J］.海峡药学,2010,22(1):150-151.

［10］PUNTILLO K A, NAIDU R. Chronic pain disorders after critical illness and ICUacquired opioid dependence: two clinical conundra［J］. Curr Opin Crit Care, 2016,22(5):506-512.

［11］陆蕴华.医疗机构麻醉和精神药品管理中存在的问题及对策［J］.中国处方药,2019,17(1):46-47.

［12］张凤莲,于腾飞.“四查十对”对于药剂师的重要性［J］.中国实用医药,2009,4(35):264-265.